Skip to main content
. 2022 Jun 7;14(6):1215. doi: 10.3390/pharmaceutics14061215

Figure 10.

Figure 10

QPI. Representative image at 0, 24, 48, and 72 h of BR6 cells (A) and NLF cells (B) treated with Nanospermidine (NS, 200 μM spermidine) as a single agent and in combination with Nanofenretinide (NF, 10 µM fenretinide). As a comparison, the images of the untreated cells and the cells treated with NF are shown.